Accelerating AI-Powered Documentation in Regulated Industries

Akkodis and Biolevate join forces Accelerating AI-Powered Documentation in Regulated Industries

2026-10-26 Source: Press release Akkodis | Translated by AI 3 min Reading Time

Related Vendors

GGB Heilbronn GmbH

Fastems Systems GmbH

item Industrietechnik GmbH

A strategic partnership combines Biolevate’s AI platform with Akkodis’ engineering, validation and regulatory expertise. Companies in life sciences, aerospace, defence and energy are expected to benefit from increased productivity and more efficient compliance processes.

Akkodis and Biolevate are combining AI-powered documentation technology with engineering and regulatory expertise to streamline workflows in highly regulated industries.(Source: felixioncool on Pixabay) — Akkodis and Biolevate are combining AI-powered documentation technology with engineering and regulatory expertise to streamline workflows in highly regulated industries.
(Source: felixioncool on Pixabay)

Akkodis, a global digital engineering consulting company and part of the Adecco Group, and Biolevate, a company specialising in AI solutions for the life sciences industry, have announced a strategic partnership. Together, they aim to accelerate scientific, regulatory and technical documentation processes in highly regulated industries using artificial intelligence.

The partnership will initially launch in France and Belgium, with plans to expand into additional markets. It combines Biolevate’s AI platform with Akkodis’ engineering, validation and regulatory expertise to help organisations meet compliance requirements more efficiently, reduce documentation workloads and accelerate innovation.

In highly regulated industries, scientific, technical and compliance-related documentation is essential for product approvals, quality assurance, patient safety and adherence to regulatory requirements. However, as the volume and complexity of this documentation increase, manual and resource-intensive processes are increasingly reaching their limits. Demand is consequently growing for AI-powered documentation solutions that boost productivity while maintaining compliance, traceability and expert oversight.

The Akkodis and Biolevate partnership addresses these challenges by combining AI-powered automation with in-depth industry expertise and controlled workflows specifically designed for regulated environments. According to Biolevate, this approach can make scientific literature reviews up to 2.5 times faster. At the same time, preparation times for clinical study reports and regulatory submission dossiers can be reduced by up to 50 per cent, while medical device development processes can be shortened by up to 30 per cent.

The ideal combination of technology and expertise

Akkodis brings extensive expertise in life sciences, validation engineering, quality management, regulatory compliance and AI transformation. The company supports organisations in implementing, validating and scaling technology-enabled processes in complex and highly regulated environments, bridging the gap between innovative technologies and their successful practical application.

Biolevate provides ELISE, an AI-powered knowledge and workflow platform designed for regulated environments. Using natural language processing, computer vision and graph-based AI models, the platform helps organisations manage scientific and regulatory documentation and knowledge management processes more efficiently.

ELISE draws on controlled data sources and traceable evidence, incorporating structured review and approval processes involving subject-matter experts. This enables organisations to use AI consistently and transparently, while maintaining auditability. Reusable templates, predefined methodologies and standardised review processes also help preserve institutional knowledge and harmonise documentation workflows across teams.

The joint offering combines Biolevate’s AI-powered knowledge and workflow platform with Akkodis’ consulting, engineering, quality, validation and regulatory expertise. The aim is to support customers in implementing and scaling AI-powered documentation processes.

Together, the companies enable organisations to deploy AI productively in scientific, regulatory and compliance-critical processes with stringent requirements, without compromising transparency, traceability or expert oversight.

Scalable use cases for regulated environments

The partnership supports a range of business-critical processes in regulated settings, including:

Scientific documentation: Systematic literature reviews, clinical study reports and other scientific documentation.
Regulatory documentation and medical communications: Regulatory submission dossiers, filing documentation, medical communications and regulatory intelligence processes.
Medical device development: Product development processes that support regulatory requirements and lifecycle management.

“This partnership embodies the core of Akkodis Intelligence: combining advanced AI with deep human expertise to modernise scientific, regulatory and technical documentation,” says Jo Debecker, President and CEO of Akkodis. “Companies in highly regulated industries need more than powerful AI models. They need controlled workflows that support informed expert decisions. Together, Akkodis and Biolevate help customers deploy AI productively in a way that is scalable, traceable and aligned with regulatory requirements.”

Subscribe to the newsletter now

Don't Miss out on Our Best Content

Business E-mail

Please enter a valid mailadress.

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta).

Date: 08.12.2025

Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.

Consent to the use of data for promotional purposes

I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here

Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.

Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.

In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.

Right of revocation

I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.

“Biolevate’s mission is to pave the way for faster therapies by bringing innovation where it is needed most,” says Joël Belafa, co-founder and CEO of Biolevate. “Our partnership with Akkodis enables scientists, engineers and regulatory teams to rethink the way they work in the age of AI. This allows them to increase productivity, preserve critical knowledge and bring high-quality solutions to market faster. For us, this is a significant milestone in addressing this challenge on a much larger scale. Akkodis is recognised worldwide for the quality of its experts and its strategic influence across a wide range of markets.”